Kansas City VA Medical Center, Kansas City, MO

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder	Recruiting	Phase 2	2026-09-17	NCT05011383
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer	Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fanconi anemia complementation group D1, Fanconi anemia complementation group N, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, central nervous system malformation, hereditary disease, hereditary sensory and autonomic neuropathy, inherited neurodegenerative disorder, male reproductive organ cancer, male reproductive system disorder, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, prostate cancer, prostate disorder	Recruiting	Phase 2	2026-09-17	NCT04038502
High Intensity Interval Training (HIIT) to Reduce Frailty and Enhance Resilience in Older Veterans	Frailty, Pathologic Processes, Pathological Conditions, Signs and Symptoms	Recruiting	Not applicable	2025-12-12	NCT05625204

Clinical trials